nodes	percent_of_prediction	percent_of_DWPC	metapath
Clenbuterol—ADRB2—autistic disorder	0.681	1	CbGaD
Clenbuterol—NGF—eye—autistic disorder	0.00817	0.147	CbGeAlD
Clenbuterol—NGF—forebrain—autistic disorder	0.0081	0.146	CbGeAlD
Clenbuterol—NGF—telencephalon—autistic disorder	0.00745	0.134	CbGeAlD
Clenbuterol—NGF—head—autistic disorder	0.00464	0.0834	CbGeAlD
Clenbuterol—NGF—nervous system—autistic disorder	0.0044	0.0791	CbGeAlD
Clenbuterol—NGF—central nervous system—autistic disorder	0.00423	0.0761	CbGeAlD
Clenbuterol—NGF—brain—autistic disorder	0.00336	0.0604	CbGeAlD
Clenbuterol—Bambuterol—ADRB2—autistic disorder	0.00255	0.301	CrCbGaD
Clenbuterol—CYP1A1—mouth—autistic disorder	0.00216	0.0388	CbGeAlD
Clenbuterol—ADRB1—forebrain—autistic disorder	0.00211	0.0379	CbGeAlD
Clenbuterol—ADRB1—telencephalon—autistic disorder	0.00194	0.0349	CbGeAlD
Clenbuterol—Pirbuterol—ADRB2—autistic disorder	0.00194	0.228	CrCbGaD
Clenbuterol—Terbutaline—ADRB2—autistic disorder	0.00158	0.186	CrCbGaD
Clenbuterol—Bupranolol—ADRB2—autistic disorder	0.00125	0.147	CrCbGaD
Clenbuterol—ADRB1—head—autistic disorder	0.00121	0.0217	CbGeAlD
Clenbuterol—Salbutamol—ADRB2—autistic disorder	0.00117	0.138	CrCbGaD
Clenbuterol—ADRB1—nervous system—autistic disorder	0.00114	0.0206	CbGeAlD
Clenbuterol—ADRB1—central nervous system—autistic disorder	0.0011	0.0198	CbGeAlD
Clenbuterol—CYP1A2—digestive system—autistic disorder	0.000968	0.0174	CbGeAlD
Clenbuterol—CYP1A1—digestive system—autistic disorder	0.000955	0.0172	CbGeAlD
Clenbuterol—ADRB1—brain—autistic disorder	0.000875	0.0157	CbGeAlD
Clenbuterol—CYP1A1—head—autistic disorder	0.000779	0.014	CbGeAlD
Clenbuterol—CYP1A1—nervous system—autistic disorder	0.000738	0.0133	CbGeAlD
Clenbuterol—CYP1A1—central nervous system—autistic disorder	0.000711	0.0128	CbGeAlD
Clenbuterol—CYP1A1—brain—autistic disorder	0.000564	0.0101	CbGeAlD
Clenbuterol—CYP1A1—Metabolism—SLC25A12—autistic disorder	3.62e-05	0.000142	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—CALCA—autistic disorder	3.6e-05	0.000141	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR ligand binding—POMC—autistic disorder	3.59e-05	0.000141	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—CALCA—autistic disorder	3.58e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GHR—autistic disorder	3.58e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL5—autistic disorder	3.56e-05	0.00014	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—WNT2—autistic disorder	3.55e-05	0.000139	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDE4A—autistic disorder	3.52e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—CALCA—autistic disorder	3.52e-05	0.000138	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—SLC19A1—autistic disorder	3.52e-05	0.000138	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GHR—autistic disorder	3.5e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—POMC—autistic disorder	3.49e-05	0.000137	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IGF1—autistic disorder	3.48e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PRKCB—autistic disorder	3.48e-05	0.000137	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDE4A—autistic disorder	3.45e-05	0.000135	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—PIK3CG—autistic disorder	3.33e-05	0.000131	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—ADRB2—autistic disorder	3.32e-05	0.00013	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—SERPINE1—autistic disorder	3.31e-05	0.00013	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AVPR1A—autistic disorder	3.3e-05	0.000129	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TDO2—autistic disorder	3.24e-05	0.000127	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	3.24e-05	0.000127	CbGpPWpGaD
Clenbuterol—CYP1A2—Biological oxidations—POMC—autistic disorder	3.23e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AVPR1A—autistic disorder	3.23e-05	0.000127	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—VIP—autistic disorder	3.19e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GRM5—autistic disorder	3.19e-05	0.000125	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—POMC—autistic disorder	3.17e-05	0.000124	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PRL—autistic disorder	3.16e-05	0.000124	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADSL—autistic disorder	3.14e-05	0.000123	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—AVP—autistic disorder	3.12e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—VIP—autistic disorder	3.12e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GRM5—autistic disorder	3.12e-05	0.000122	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—OXTR—autistic disorder	3.09e-05	0.000121	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—XDH—autistic disorder	3.08e-05	0.000121	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SCT—autistic disorder	3.06e-05	0.00012	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—AVP—autistic disorder	3.05e-05	0.00012	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DHCR7—autistic disorder	3.05e-05	0.000119	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—STX1A—autistic disorder	3.02e-05	0.000118	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—NPAS2—autistic disorder	3.02e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—OXTR—autistic disorder	3.02e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—ADRB2—autistic disorder	3.02e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ADRB2—autistic disorder	3e-05	0.000118	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SCT—autistic disorder	2.99e-05	0.000117	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TCN2—autistic disorder	2.92e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GABBR1—autistic disorder	2.91e-05	0.000114	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADM—autistic disorder	2.91e-05	0.000114	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—EXT1—autistic disorder	2.89e-05	0.000113	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC6A8—autistic disorder	2.89e-05	0.000113	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EIF4E—autistic disorder	2.86e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GABBR1—autistic disorder	2.85e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ADM—autistic disorder	2.85e-05	0.000112	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PDE4B—autistic disorder	2.84e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—AVP—autistic disorder	2.83e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—AVP—autistic disorder	2.82e-05	0.000111	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF2—autistic disorder	2.81e-05	0.00011	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EIF4E—autistic disorder	2.8e-05	0.00011	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—ADA—autistic disorder	2.78e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PDE4B—autistic disorder	2.78e-05	0.000109	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—AVP—autistic disorder	2.77e-05	0.000109	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DAO—autistic disorder	2.75e-05	0.000108	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	2.75e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—OPRM1—autistic disorder	2.75e-05	0.000108	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—OPRM1—autistic disorder	2.69e-05	0.000106	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL2—autistic disorder	2.68e-05	0.000105	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PLA2G4A—autistic disorder	2.66e-05	0.000104	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PLA2G4A—autistic disorder	2.65e-05	0.000104	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—UPB1—autistic disorder	2.64e-05	0.000104	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	2.63e-05	0.000103	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PLA2G4A—autistic disorder	2.61e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—HTR2A—autistic disorder	2.6e-05	0.000102	CbGpPWpGaD
Clenbuterol—ADRB3—GPCR downstream signaling—IL2—autistic disorder	2.58e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MEF2C—autistic disorder	2.58e-05	0.000101	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—HTR2A—autistic disorder	2.54e-05	9.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—RORA—autistic disorder	2.54e-05	9.95e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—PTEN—autistic disorder	2.52e-05	9.88e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—GZMB—autistic disorder	2.52e-05	9.87e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—ITGB3—autistic disorder	2.51e-05	9.86e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—GZMB—autistic disorder	2.46e-05	9.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM5—autistic disorder	2.45e-05	9.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ASMT—autistic disorder	2.45e-05	9.63e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR1B—autistic disorder	2.44e-05	9.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—OXT—autistic disorder	2.44e-05	9.58e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR1B—autistic disorder	2.39e-05	9.37e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—OXT—autistic disorder	2.39e-05	9.37e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MAOB—autistic disorder	2.38e-05	9.33e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HTR2A—autistic disorder	2.36e-05	9.25e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HTR2A—autistic disorder	2.35e-05	9.2e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL2—autistic disorder	2.35e-05	9.2e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC25A12—autistic disorder	2.31e-05	9.05e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HTR2A—autistic disorder	2.31e-05	9.05e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PRKCB—autistic disorder	2.28e-05	8.93e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TSC1—autistic disorder	2.27e-05	8.9e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD1—autistic disorder	2.27e-05	8.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—APOE—autistic disorder	2.26e-05	8.88e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—SLC19A1—autistic disorder	2.24e-05	8.8e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—MAPK1—autistic disorder	2.24e-05	8.8e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—TSC2—autistic disorder	2.23e-05	8.74e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PRKCB—autistic disorder	2.23e-05	8.73e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD1—autistic disorder	2.22e-05	8.71e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TSC1—autistic disorder	2.22e-05	8.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—TPH2—autistic disorder	2.21e-05	8.67e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—NTRK2—autistic disorder	2.21e-05	8.66e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—DRD3—autistic disorder	2.2e-05	8.62e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—LEP—autistic disorder	2.18e-05	8.56e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APOE—autistic disorder	2.18e-05	8.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—PIK3CG—autistic disorder	2.18e-05	8.54e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DPYD—autistic disorder	2.18e-05	8.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—NTRK2—autistic disorder	2.16e-05	8.47e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL5—autistic disorder	2.15e-05	8.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—DRD3—autistic disorder	2.15e-05	8.44e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—PIK3CG—autistic disorder	2.13e-05	8.36e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—CALCA—autistic disorder	2.13e-05	8.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL5—autistic disorder	2.11e-05	8.26e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—CALCA—autistic disorder	2.08e-05	8.16e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—POMC—autistic disorder	2.07e-05	8.13e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PRKCB—autistic disorder	2.07e-05	8.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—CYP19A1—autistic disorder	2.06e-05	8.09e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PRKCB—autistic disorder	2.06e-05	8.07e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—MAPK1—autistic disorder	2.05e-05	8.03e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	2.04e-05	8.01e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—POMC—autistic disorder	2.03e-05	7.96e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PRKCB—autistic disorder	2.02e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CACNA1C—autistic disorder	2.02e-05	7.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADSL—autistic disorder	2e-05	7.85e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—PIK3CG—autistic disorder	1.98e-05	7.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—APC—autistic disorder	1.97e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PIK3CG—autistic disorder	1.97e-05	7.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—XDH—autistic disorder	1.96e-05	7.7e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—EGF—autistic disorder	1.95e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.94e-05	7.63e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—PIK3CG—autistic disorder	1.94e-05	7.59e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—STX1A—autistic disorder	1.93e-05	7.55e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—NPAS2—autistic disorder	1.93e-05	7.55e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—POMC—autistic disorder	1.88e-05	7.39e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRL—autistic disorder	1.88e-05	7.37e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—POMC—autistic disorder	1.87e-05	7.35e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TCN2—autistic disorder	1.86e-05	7.29e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—POMC—autistic disorder	1.84e-05	7.22e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—DHFR—autistic disorder	1.84e-05	7.21e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRL—autistic disorder	1.84e-05	7.21e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IGF1—autistic disorder	1.8e-05	7.07e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—HRAS—autistic disorder	1.8e-05	7.06e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—MAPK1—autistic disorder	1.79e-05	7.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ADRB2—autistic disorder	1.78e-05	6.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—ADA—autistic disorder	1.77e-05	6.96e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PLA2G4A—autistic disorder	1.75e-05	6.88e-05	CbGpPWpGaD
Clenbuterol—TNF—Developmental Biology—IL6—autistic disorder	1.72e-05	6.76e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—SERPINE1—autistic disorder	1.71e-05	6.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—GPX1—autistic disorder	1.68e-05	6.59e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—AVP—autistic disorder	1.67e-05	6.56e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF2—autistic disorder	1.67e-05	6.54e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—HRAS—autistic disorder	1.64e-05	6.45e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—AVP—autistic disorder	1.64e-05	6.42e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF2—autistic disorder	1.63e-05	6.39e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—RORA—autistic disorder	1.62e-05	6.35e-05	CbGpPWpGaD
Clenbuterol—NGF—Signaling Pathways—IL6—autistic disorder	1.57e-05	6.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PLA2G4A—autistic disorder	1.57e-05	6.17e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	1.55e-05	6.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PLA2G4A—autistic disorder	1.54e-05	6.04e-05	CbGpPWpGaD
Clenbuterol—ADRB1—GPCR downstream signaling—IL2—autistic disorder	1.53e-05	6.01e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MEF2C—autistic disorder	1.53e-05	6e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MAOB—autistic disorder	1.52e-05	5.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—GPCR downstream signaling—IL2—autistic disorder	1.5e-05	5.88e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MEF2C—autistic disorder	1.5e-05	5.87e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—ITGB3—autistic disorder	1.49e-05	5.85e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—ITGB3—autistic disorder	1.46e-05	5.72e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—APOE—autistic disorder	1.44e-05	5.66e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CYP19A1—autistic disorder	1.44e-05	5.65e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—HRAS—autistic disorder	1.44e-05	5.65e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—TPH2—autistic disorder	1.41e-05	5.53e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HTR2A—autistic disorder	1.39e-05	5.46e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL2—autistic disorder	1.39e-05	5.46e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DPYD—autistic disorder	1.39e-05	5.44e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL2—autistic disorder	1.39e-05	5.43e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling by GPCR—IL6—autistic disorder	1.38e-05	5.41e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HTR2A—autistic disorder	1.36e-05	5.34e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL2—autistic disorder	1.36e-05	5.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	1.35e-05	5.3e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—COMT—autistic disorder	1.34e-05	5.25e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTP1—autistic disorder	1.33e-05	5.23e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MAOA—autistic disorder	1.33e-05	5.22e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—TSC2—autistic disorder	1.32e-05	5.19e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—PTEN—autistic disorder	1.3e-05	5.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PIK3CG—autistic disorder	1.3e-05	5.11e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—CAT—autistic disorder	1.3e-05	5.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—LEP—autistic disorder	1.3e-05	5.08e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APOE—autistic disorder	1.3e-05	5.08e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—TSC2—autistic disorder	1.29e-05	5.08e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CACNA1C—autistic disorder	1.29e-05	5.06e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—LEP—autistic disorder	1.27e-05	4.97e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APOE—autistic disorder	1.27e-05	4.97e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—POMC—autistic disorder	1.24e-05	4.86e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GSTM1—autistic disorder	1.23e-05	4.8e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PLA2G4A—autistic disorder	1.23e-05	4.8e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PRKCB—autistic disorder	1.22e-05	4.79e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PRKCB—autistic disorder	1.19e-05	4.68e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—GPX1—autistic disorder	1.17e-05	4.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—DHFR—autistic disorder	1.17e-05	4.6e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PIK3CG—autistic disorder	1.17e-05	4.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—APC—autistic disorder	1.17e-05	4.58e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—EGF—autistic disorder	1.16e-05	4.53e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—APC—autistic disorder	1.14e-05	4.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PIK3CG—autistic disorder	1.14e-05	4.48e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—EGF—autistic disorder	1.13e-05	4.43e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—POMC—autistic disorder	1.11e-05	4.36e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—POMC—autistic disorder	1.09e-05	4.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—MTHFR—autistic disorder	1.08e-05	4.25e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IGF1—autistic disorder	1.07e-05	4.2e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—MAPK1—autistic disorder	1.06e-05	4.18e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—MAPK1—autistic disorder	1.06e-05	4.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IGF1—autistic disorder	1.05e-05	4.11e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—MAPK1—autistic disorder	1.04e-05	4.09e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—SERPINE1—autistic disorder	1.02e-05	3.99e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—APOE—autistic disorder	1.01e-05	3.95e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—SERPINE1—autistic disorder	9.94e-06	3.9e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—autistic disorder	9.89e-06	3.88e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CYP19A1—autistic disorder	9.19e-06	3.6e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PIK3CG—autistic disorder	9.1e-06	3.57e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—POMC—autistic disorder	8.66e-06	3.4e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism of lipids and lipoproteins—PTEN—autistic disorder	8.62e-06	3.38e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—HRAS—autistic disorder	8.55e-06	3.35e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—COMT—autistic disorder	8.54e-06	3.35e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—HRAS—autistic disorder	8.51e-06	3.34e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTP1—autistic disorder	8.5e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MAOA—autistic disorder	8.48e-06	3.33e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—HRAS—autistic disorder	8.36e-06	3.28e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—CAT—autistic disorder	8.27e-06	3.24e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL2—autistic disorder	8.22e-06	3.23e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling by GPCR—IL6—autistic disorder	8.18e-06	3.21e-05	CbGpPWpGaD
Clenbuterol—ADRB3—Signaling Pathways—IL6—autistic disorder	8.14e-06	3.19e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL2—autistic disorder	8.05e-06	3.16e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling by GPCR—IL6—autistic disorder	8.01e-06	3.14e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GSTM1—autistic disorder	7.81e-06	3.06e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PLA2G4A—autistic disorder	7.81e-06	3.06e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—PTEN—autistic disorder	7.74e-06	3.03e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—PTEN—autistic disorder	7.57e-06	2.97e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—GPX1—autistic disorder	7.48e-06	2.93e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTGS2—autistic disorder	6.91e-06	2.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—MTHFR—autistic disorder	6.9e-06	2.71e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—APOE—autistic disorder	6.43e-06	2.52e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—MAPK1—autistic disorder	6.29e-06	2.47e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—MAPK1—autistic disorder	6.15e-06	2.41e-05	CbGpPWpGaD
Clenbuterol—CYP1A1—Metabolism—PTEN—autistic disorder	6.02e-06	2.36e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PIK3CG—autistic disorder	5.8e-06	2.27e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—POMC—autistic disorder	5.52e-06	2.17e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—HRAS—autistic disorder	5.05e-06	1.98e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—HRAS—autistic disorder	4.94e-06	1.94e-05	CbGpPWpGaD
Clenbuterol—ADRB1—Signaling Pathways—IL6—autistic disorder	4.83e-06	1.9e-05	CbGpPWpGaD
Clenbuterol—ADRB2—Signaling Pathways—IL6—autistic disorder	4.73e-06	1.85e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTGS2—autistic disorder	4.4e-06	1.73e-05	CbGpPWpGaD
Clenbuterol—CYP1A2—Metabolism—PTEN—autistic disorder	3.84e-06	1.51e-05	CbGpPWpGaD
